PATENT CLAIM ANALYSIS

Application Number: 16059781
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "078310"]

Abstract:
One aspect of the present invention relates generally to injectable compositions. In one embodiment, the compositions include 2-hydroxyethyl methacrylate and a dimethacrylate crosslinker. Another aspect of the invention relates generally to methods of using such compositions for thermal ablation and for the occlusion of body vessels.

Claim (Index 13):
The method of  claim 1 , wherein the first composition comprises\n 95 to 99.5% v/v 2-hydroxyethyl methacrylate; 0.5% to 1% v/v dimethacrylate crosslinker; 0.1% to 0.3% weight 1,4-diazabicyclooctane; and 0.05% to 0.2% weight 1-[4-(2-Hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propane-1-one, and wherein the isocyanate is lysine triisocyanate.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 96.0
- Lexical Diversity: 1.51515
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10862177', '15106754', '16037572', '11205047', '15704792']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7216830090047022
- 35 USC 102 Novelty (BERT): 0.4864396436330773
- Combined Prediction Score: 0.6981586724675397
- Mean Citation Score: 134.334482
- Max Citation Score: 140.38373
- Similarity Product: 88.82806100286365

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test